Cargando…
Differential response of HBV envelope-specific CD4(+) T cells is related to HBsAg loss after stopping nucleos(t)ide analogue therapy
Long-term maintenance of viral control, even HBsAg loss, remains a challenge for chronic hepatitis B (CHB) patients undergoing nucleos(t)ide analogue (NA) discontinuation. This study aimed to investigate the relationship between HBV-specific T-cell responses targeting peptides spanning the whole pro...
Autores principales: | Li, Yongyin, Wen, Chunhua, Gu, Shuqin, Wang, Weibin, Guo, Ling, Li, Chris Kafai, Yi, Xuan, Zhou, Yang, Dong, Zheyu, Fu, Xin, Zhong, Shihong, Wang, Yuhao, Huang, Kuiyuan, Yin, Junhua, Zhong, Chunxiu, Liang, Xieer, Fan, Rong, Chen, Haitao, Jiang, Deke, Zhang, Xiaoyong, Sun, Jian, Tang, Libo, Peng, Jie, Hou, Jinlin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344436/ https://www.ncbi.nlm.nih.gov/pubmed/36896974 http://dx.doi.org/10.1097/HEP.0000000000000334 |
Ejemplares similares
-
The potential effect of HBV vaccination on off-treatment HBsAg reversion after interferon-induced HBsAg clearance
por: Jiang, Shaowen, et al.
Publicado: (2023) -
Unexpected rise in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and vaccination strategies
por: Piermatteo, Lorenzo, et al.
Publicado: (2023) -
The presence of baseline HBsAb-Specific B cells can predict HBsAg or HBeAg seroconversion of chronic hepatitis B on treatment
por: Yin, Shengxia, et al.
Publicado: (2023) -
Lower end of treatment HBsAg and HBcrAg were associated with HBsAg loss after nucleos(t)ide analog cessation
por: Xie, Yandi, et al.
Publicado: (2023) -
Estimating the Net Contribution of Interleukin-28B Variation to Spontaneous Hepatitis C Virus Clearance
por: di Iulio, Julia, et al.
Publicado: (2011)